NEW YORK, July 29 (Our New York News) — For many patients, the biggest change from artificial intelligence may not be a robot in the exam room. It may be a doctor who gets a faster warning that something is wrong, a treatment plan tailored more closely to a person’s genes and medical history, or a wearable device that spots a problem before it becomes serious.
That is the direction described in an IEEE report on health technology, as summarized by Fox Business. The report ranked personalized medicine, gene therapy and early disease diagnostics among the areas with the highest expected impact and the strongest chance of success.
What AI could change first
The clearest near-term use of AI in healthcare is not to replace clinicians, but to help them make better decisions. A review published in PubMed Central says AI is already being used for disease detection, personalized care, drug discovery, predictive analytics, telemedicine and wearable health technology.
That same review says AI can analyze electronic health records, medical images and genomic profiles to find patterns, predict how disease may progress and suggest better treatment choices.
Another review says the meeting point of AI and precision medicine could reshape healthcare by giving doctors and patients more personalized diagnostic and treatment information. A separate review says AI-enabled tools may improve diagnostic accuracy, treatment strategies and patient outcomes.
What do these terms mean?
Personalized medicine, also called precision medicine, means care that is adjusted to the individual instead of using one plan for everyone. Doctors may look at a person’s genes, medical history, lifestyle and test results to guide care.
Gene therapy is different. It aims to treat disease by changing or replacing genes inside the body. In the IEEE report, gene therapy was one of the areas expected to have a large impact.
Early diagnostics and biomarkers are also key. Biomarkers are measurable signs in the body that can point to disease risk or disease activity. The IEEE report ranked accessible early disease diagnostics and biomarkers highly for impact, success, maturity and adoption.
Why these areas matter for everyday life
The practical value for patients is simple: earlier answers, better matched care and fewer trial-and-error decisions.
The IEEE report says health-tech advances over the next five to 10 years could help reduce preventable chronic diseases and improve personalized clinical outcomes. It also says they could improve food safety and expand access to high-quality, nutrient-dense foods.
In a quote reported by Fox Business, Dejan Milojicic, chair of the IEEE Future Directions Committee Industry Advisory Board, said health technologies are “among the most transformative and humanity-beneficial, driven by a fundamental shift from reactive treatment to proactive protection.”
He also said physical AI tools, such as virtual nursing and intelligent monitoring, could become important as populations age.
What could slow this down?
The IEEE report also points to barriers. It says privacy and security concerns remain a major obstacle, especially when health data are used for public-health prevention through epidemiology and surveillance. It also points to resistance from status-quo culture.
That matters because many AI systems depend on large amounts of data. If that data is not protected, patients may worry about how their information is used. If the systems are not trusted, hospitals and doctors may be slower to adopt them.
What to watch next
The reviews in PubMed Central suggest that AI’s biggest effect will likely come through several connected tools at once: better imaging, stronger use of genomic data, wearable devices, multi-omics data that combines different layers of biological information, and more customized care.
One review lays out a timeline in which precision imaging is a short-term use, while larger-scale precision imaging, synthetic biology, customized care and other applications grow in the medium term. It also says long-term uses could include genomics medicine, AI-driven drug discovery and new curative treatments.
For readers, that means the shift is likely to be gradual, not sudden. The first signs may show up as faster test results, more targeted treatment plans and better monitoring for chronic disease. Over time, the changes could reach much further into how medicine is delivered, how drugs are designed and how early disease is found.
